Plante Moran Financial Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22K | Buy |
255
+52
| +26% | +$4.56K | ﹤0.01% | 462 |
|
|
2026
Q1 | $18.4K | Hold |
203
| – | – | ﹤0.01% | 438 |
|
|
2025
Q4 | $18.3K | Buy |
203
+100
| +97% | +$9.48K | ﹤0.01% | 462 |
|
|
2025
Q3 | $10.2K | Hold |
103
| – | – | ﹤0.01% | 546 |
|
|
2025
Q2 | $9.43K | Hold |
103
| – | – | ﹤0.01% | 568 |
|
|
2025
Q1 | $11.7K | Hold |
103
| – | – | ﹤0.01% | 545 |
|
|
2024
Q4 | $10.9K | Hold |
103
| – | – | ﹤0.01% | 563 |
|
|
2024
Q3 | $11.2K | Hold |
103
| – | – | ﹤0.01% | 597 |
|
|
2024
Q2 | $11.2K | Hold |
103
| – | – | ﹤0.01% | 569 |
|
|
2024
Q1 | $13.6K | Hold |
103
| – | – | ﹤0.01% | 564 |
|
|
2023
Q4 | $12.6K | Sell |
103
-30
| -23% | -$3.35K | ﹤0.01% | 523 |
|
|
2023
Q3 | $15K | Sell |
133
-4
| -3% | -$508 | ﹤0.01% | 475 |
|
|
2023
Q2 | $20K | Buy |
137
+4
| +3% | +$544 | ﹤0.01% | 443 |
|
|
2023
Q1 | $17.2K | Hold |
133
| – | – | ﹤0.01% | 478 |
|
|
2022
Q4 | $17K | Hold |
133
| – | – | ﹤0.01% | 499 |
|
|
2022
Q3 | $14K | Hold |
133
| – | – | ﹤0.01% | 539 |
|
|
2022
Q2 | $14K | Hold |
133
| – | – | ﹤0.01% | 549 |
|
|
2022
Q1 | $17K | Sell |
133
-49
| -27% | -$5.91K | ﹤0.01% | 531 |
|
|
2021
Q4 | $23K | Sell |
182
-233
| -56% | -$30.5K | ﹤0.01% | 534 |
|
|
2021
Q3 | $59K | Buy |
415
+309
| +292% | +$45.5K | 0.01% | 357 |
|
|
2021
Q2 | $17K | Hold |
106
| – | – | ﹤0.01% | 595 |
|
|
2021
Q1 | $17K | Sell |
106
-593
| -85% | -$91.9K | ﹤0.01% | 561 |
|
|
2020
Q4 | $105K | Buy |
699
+508
| +266% | +$71.7K | 0.03% | 245 |
|
|
2020
Q3 | $25K | Hold |
191
| – | – | 0.01% | 449 |
|
|
2020
Q2 | $22K | Sell |
191
-155
| -45% | -$17.9K | 0.01% | 417 |
|
|
2020
Q1 | $34K | Sell |
346
-42
| -11% | -$5.51K | 0.02% | 317 |
|
|
2019
Q4 | $56K | Buy |
388
+34
| +10% | +$4.69K | 0.02% | 309 |
|
|
2019
Q3 | $47K | Sell |
354
-196
| -36% | -$25.3K | 0.01% | 349 |
|
|
2019
Q2 | $63K | Sell |
550
-135
| -20% | -$15.8K | 0.02% | 292 |
|
|
2019
Q1 | $85K | Hold |
685
| – | – | 0.03% | 238 |
|
|
2018
Q4 | $69K | Buy |
685
+405
| +145% | +$45.5K | 0.02% | 250 |
|
|
2018
Q3 | $36K | Buy |
280
+84
| +43% | +$9.99K | 0.01% | 359 |
|
|
2018
Q2 | $21K | Hold |
196
| – | – | 0.01% | 469 |
|
|
2018
Q1 | $21K | Hold |
196
| – | – | 0.01% | 503 |
|
|
2017
Q4 | $23K | Hold |
196
| – | – | 0.01% | 481 |
|
|
2017
Q3 | $22K | Hold |
196
| – | – | 0.01% | 451 |
|
|
2017
Q2 | $24K | Sell |
196
-77
| -28% | -$9.13K | 0.02% | 446 |
|
|
2017
Q1 | $32K | Buy |
273
+77
| +39% | +$8.73K | 0.02% | 396 |
|
|
2016
Q4 | $20K | Sell |
196
-31
| -14% | -$3.32K | 0.01% | 487 |
|
|
2016
Q3 | $29K | Sell |
227
-6
| -3% | -$741 | 0.02% | 415 |
|
|
2016
Q2 | $27K | Hold |
233
| – | – | 0.02% | 385 |
|
|
2016
Q1 | $24K | Buy |
233
+37
| +19% | +$3.58K | 0.02% | 361 |
|
|
2015
Q4 | $19K | Sell |
196
-104
| -35% | -$10.2K | 0.01% | 461 |
|
|
2015
Q3 | $27K | Hold |
300
| – | – | 0.02% | 350 |
|
|
2015
Q2 | $32K | Hold |
300
| – | – | 0.02% | 359 |
|
|
2015
Q1 | $34K | Hold |
300
| – | – | 0.02% | 335 |
|
|
2014
Q4 | $33K | Hold |
300
| – | – | 0.02% | 337 |
|
|
2014
Q3 | $29K | Buy |
300
+20
| +7% | +$1.97K | 0.03% | 351 |
|
|
2014
Q2 | $28K | Sell |
280
-75
| -21% | -$7.32K | 0.03% | 331 |
|
|
2014
Q1 | $33K | Hold |
355
| – | – | 0.04% | 203 |
|
|
2013
Q4 | $32K | Hold |
355
| – | – | 0.02% | 292 |
|
|
2013
Q3 | $28K | Hold |
355
| – | – | 0.02% | 249 |
|
|
2013
Q2 | $26K | Buy |
+355
| New | +$26.5K | 0.02% | 225 |
|
Other funds holding ZBH
EIC
SCM
BTW
Plante Moran Financial Advisors's ZBH Position: Q2 2026 in Review
Plante Moran Financial Advisors increased its Zimmer Biomet (ZBH) stake by 26% in Q2 2026, buying an estimated $4.56K and bringing the position to 255 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #462.
Plante Moran Financial Advisors first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $105K in Q4 2020. 489 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Plante Moran Financial Advisors held 255 shares of Zimmer Biomet worth $22K as of Q2 2026.
- Plante Moran Financial Advisors bought 52 Zimmer Biomet shares in Q2 2026, an estimated $4.56K.
- Zimmer Biomet made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #462 holding.
- Plante Moran Financial Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Plante Moran Financial Advisors's Zimmer Biomet position peaked at $105K in Q4 2020.
- 489 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.